The rise in chronic diseases is driving demand for advanced autoinjector solutions, enabling patients to self-administer essential biologics and biosimilars at home with greater convenience and control.

Jarus will have global responsibility for driving innovation and developing new solutions and applications across all markets by collaborating with

Composites will play an increasingly larger role in driving our future growth."

Patterson currently serves as executive vice president and chief operating officer, where he is responsible for developing and executing the annual operating plans and strategic plans to drive growth in revenue, gross margin and operating income.

We will leverage our best-in-class technical, commercial and operational capabilities to drive growth for this new business, PolyOne, and most importantly our customers.”

What performance factors drive your preference for aluminum or steel in part design?

Page 93 • Versus 2010, revenue growth of 9% drives 23% increase in adjusted operating income • Adjusted EPS expands 29% to all-time high of $1.02 Net Sales Adjusted Operating $1.02 Adjusted EPS $2,622 $2,643 $2,739 $2,061 $2,622 $2,864 Net Sales $88 $87 $72 $59 $147 $181 Adjusted Operating Income $0.12 $0.27 $0.21 $0.13 $0.79 $1.02 ($ millions) ($ millions) Page 94 • Each platform contributed to our year over year operating income growth • Record OI achieved in Specialty and POD • Ten quarters of double-digit adjusted EPS expansion POD PP&SSpecialty Platform ROS%* 0.6% 1.5% 3.2% 4.3% 5.3% 8.4% 8.0% 2.9% 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% 6.7% 5.5% 6.1% 3.1% 5.0% 7.0% 7.2% $20 $19 $22 $28 $25 $42 $56 I POD $76 $64 $66 $31 $33 $54 $62 In PP&S $5 $13 $31 $46 $46 $87 $89 I Specialty Platform *ROS% is defined as adjusted operating income % of revenue Page 95 • Continued portfolio repositioning � Sale of SunBelt equity investment � Acquisition of specialty companies ColorMatrix and Uniplen • World-class working capital of 9.6% maintained while improving on-time delivery to 94%improving on-time delivery to 94% 81% 87% 88% 95% 93% 92% 94% 2005 2006 2007 2008 2009 2010 2011 14.3% 16.2% 14.4% 18.9% 11.7% 9.6% 9.6% 2005 2006 2007 2008 2009 2010 2011 On-Time Delivery Working Capital % of Sales Page 96 First Quarter 2012 Highlights • Revenues increased 9% over Q1 2011 to a new quarterly record • Adjusted EPS increased 12% $0.26 $0.29 Adjusted EPS • Adjusted EPS increased 12% over prior year • All platforms delivered double-digit operating income growth $25.2 $14.7 $29.1 $17.8 $16.7 Specialty PP&S POD Adjusted Operating Income $14.3 Page 97 • Total Debt at 3/31/12 Less: Cash Net Debt • Available Liquidity $706 186 $520 $360 $250 $350 $400 $450 Debt Maturities As of March 31, 2012 Debt Maturities & Liquidity Summary – 3/31/12 • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA* = 1.9x $186 156 $342 *Adjusted EBITDA TTM Pro forma for ColorMatrix $50 $0 $50 $100 $150 $200 $250 2015 2017 2020 Page 98 • Repurchased 6 million shares in 2011 Share Share RepurchaseRepurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 DividendsDividends • Expanding our sales, marketing, and technical capabilities is top Organic Organic GrowthGrowth • Targets that expand our: • Specialty offering • End market presence AcquisitionsAcquisitions Use of Cash Current Cash Balance = $186M Net Debt / EBITDA* = 1.9X • 7.9 million shares remain available for repurchase under the current authorization increased in Q1 2012 • Objective of maintaining and growing capabilities is top priority • Investing in operational and LSS initiatives • CAPEX • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions *Adjusted EBITDA TTM Pro forma for ColorMatrix Page 99 Page 100

Taking a customer-first approach, HIVIZ identified a need in the high-end market to drive recoil-damping technology forward.

We leverage a high-touch, collaborative customer service model, where our ratio of technology to sales associates is 1.1, driving rapid customer response and customization. Synergies Initial Estimate Revised Estimate Administrative $ 18 $ 20 Sourcing 24 30 Operational 18 25 Total Synergies $ 60 $ 75 CLARIANT INTEGRATION & COST SYNERGIES UPDATE 13 $1.80 $2.12 $2.75 2020E Organic 2020 PF 2020 PF w/ Synergies The cost synergies from the Clariant Masterbatch acquisition will help drive substantial margin expansion. But more significantly, we will deliver for our stakeholders through multiple value creation levers—many of which are unique to Avient: o Demand for sustainable solutions, healthcare, and composites, together with Clariant Masterbatch revenue synergies, that will drive long-term revenue growth in excess of GDP o Our differentiated technology, service and global reach are competitive advantages o Our asset-light and high-touch business model yields stable and high free cash flow conversion o Clariant Masterbatch cost synergy capture will result in significant near-term benefit In addition, we remain committed to increasing annual dividends and buying back shares, all while remaining modestly levered.

We leverage a high-touch, collaborative customer service model, where our ratio of technology to sales associates is 1.1, driving rapid customer response and customization. Synergies Initial Estimate Revised Estimate Administrative $ 18 $ 20 Sourcing 24 30 Operational 18 25 Total Synergies $ 60 $ 75 CLARIANT INTEGRATION & COST SYNERGIES UPDATE 13 $1.65 $2.00 2020E Organic 2020 PF 2020 PF w/ Synergies The cost synergies from the Clariant Masterbatch acquisition will help drive substantial margin expansion. But more significantly, we will deliver for our stakeholders through multiple value creation levers—many of which are unique to Avient: o Demand for sustainable solutions, healthcare, and composites, together with Clariant Masterbatch revenue synergies, that will drive long-term revenue growth in excess of GDP o Our differentiated technology, service and global reach are competitive advantages o Our asset-light and high-touch business model yields stable and high free cash flow conversion o Clariant Masterbatch cost synergy capture will result in significant near-term benefit In addition, we remain committed to increasing annual dividends and buying back shares, all while remaining modestly levered.